‘Les liaisons dangereuses’: Hepatitis C, Rituximab and B-cell non-Hodgkin’s lymphomas

Rituximab has provided a revolutionary contribution to the treatment of B-cell non-Hodgkin’s lymphomas (NHL). A high prevalence of hepatitis C virus (HCV) infection has been described in B-cell NHL patients. Cases of liver dysfunction in HCV-positive patients have been reported with Rituximab-contai...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marignani, Massimo, Fonzo, Michela di, Begini, Paola, Gigante, Elia, Deli, Ilaria, Pellicelli, Adriano M, Gallina, Sara, de Santis, Emanuela, Fave, Gianfranco Delle, Cox, M Christina
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2012
Materias:
Topic Highlight
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3348959/
https://ncbi.nlm.nih.gov/pubmed/22577616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v3.i2.21
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares